Tuomas Kenttä

Tuomas Kenttä

Auto-generated profile, based on publicly available information

Tuomas Kenttä

Research Unit of Internal Medicine, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, Finland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Physiological Measurement
Verified
Journal Article
Open access
HKHannu Kinnunen
Hannu Kinnunen
ARAleksi Rantanen
Aleksi Rantanen
TKTuomas Kenttä
Tuomas Kenttä
HKHeli Koskimäki
Heli Koskimäki
Objective: To validate the accuracy of the Oura ring in the quantification of resting heart rate (HR) and heart rate variability (HRV). Background: Wearable devices have become comfortable, lightweight, and technologically advanced for assessing health behavior. As an example, the novel Oura ring integrates daily physical activity and nocturnal cardiovascular measurements. Ring users can follow their autonomic nervous system responses to their daily behavior based on nightly changes in HR and HRV, and adjust their behavior accordingly after self-reflection. As wearable photoplethysmogram (PPG) can be disrupted by several confounding influences, it is crucial to demonstrate the accuracy of ring measurements. Approach: Nocturnal HR and HRV were assessed in 49 adults with simultaneous measurements from the Oura ring and the gold standard ECG measurement. Female and male participants with a wide age range (15–72 years) and physical activity status were included. Regression analysis between ECG and the ring outcomes was performed. Main results: Very high agreement between the ring and ECG was observed for nightly average HR and HRV (r2 = 0.996 and 0.980, respectively) with a mean bias of −0.63 bpm and −1.2 ms. High agreement was also observed across 5 min segments within individual nights in (r2 = 0.869 ± 0.098 and 0.765 ± 0.178 in HR and HRV, respectively). Significance: Present findings indicate high validity of the Oura ring in the assessment of nocturnal HR and HRV in healthy adults. The results show the utility of this miniaturised device as a lifestyle management tool in long-term settings. High quality PPG signal results prompt future studies utilizing ring PPG towards clinically relevant health outcomes.

19 February 2019 in Circulation
Verified
Journal Article
Closed access
PDF file
MHM. Anette E. Haukilahti
M. Anette E. Haukilahti
LHLauri Holmström
Lauri Holmström
JVJuha Vähätalo
Juha Vähätalo
TKTuomas Kenttä
Tuomas Kenttä
JTJani Tikkanen
Jani Tikkanen
MJM. Juhani Junttila
M. Juhani Junttila
Background: Despite recent progress in profiling of risk for sudden cardiac death (SCD) and prevention and intervention of cardiac diseases, SCD remains a major cause of death. Among women, the incidence of SCD is significant, but lower than in men, particularly in the premenopausal and early postmenopausal years. Possibly, as a consequence of the difference in population burden, the mechanisms and risk markers of SCD are not as well defined for women. The aim of this study was to determine the autopsy findings and causes of death among women in a large SCD population. Additionally, we sought to classify prior ECG characteristics in male and female subjects with SCD. Methods: The Fingesture study has systematically collected clinical and autopsy data from subjects with SCD in Northern Finland between 1998 and 2017. The cohort consists of 5869 subjects with SCD. Previously recorded ECGs were available and analyzed in 1101 subjects (18.8% of total population; and in 25.3% of women). Results: Female subjects with SCD were significantly older than men: 70.1±13.1 years versus 63.5±11.8 years (mean ± standard deviation, P <0.001). The most frequently identified cause of death was ischemic heart disease in both sexes: 71.7% among women versus 75.7% among men, P =0.005. In contrast, women were more likely to have nonischemic cause of SCD than men (28.3% versus 24.3%, P =0.005). The prevalence of primary myocardial fibrosis was higher among women (5.2%, n=64) than in men (2.6%, n=120; P <0.001). Female subjects with SCD were more likely to have normal prior ECG tracings (22.2% versus 15.3% in men, P <0.001). A normal ECG was even more common among nonischemic female subjects with SCD (27.8% versus 16.2% in men, P =0.009). However, ECG markers of left ventricular hypertrophy, with or without repolarization abnormalities, were more common among women (8.2%; 17.9%) than in men (4.9%; 10.6%, P =0.036; P <0.001, respectively). Conclusions: Women were considerably older at the time of SCD and more commonly had nonischemic causes. Women were also more likely to have a prior normal ECG than men, but an increased marker for SCD risk based on ECG criteria for left ventricular hypertrophy with repolarization abnormalities was more commonly observed in women.

1 July 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
HTHenri K. Terho
Henri K. Terho
JTJani T. Tikkanen
Jani T. Tikkanen
JJJuhani M. Junttila
Juhani M. Junttila
OAOlli Anttonen
Olli Anttonen
TKTuomas V. Kenttä
Tuomas V. Kenttä
HHHeikki V. Huikuri
Heikki V. Huikuri

3 May 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TKTuomas Kerola
Tuomas Kerola
AEAntti Eranti
Antti Eranti
AAAapo L. Aro
Aapo L. Aro
MHM. Anette Haukilahti
M. Anette Haukilahti
AHArttu Holkeri
Arttu Holkeri
GMGregory M. Marcus
Gregory M. Marcus
Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing.1 Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.2 By definition, the cause of that fibrosis remains unknown.

1 August 2019 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
JVJuha H. Vähätalo
Juha H. Vähätalo
HHHeikki V. Huikuri
Heikki V. Huikuri
LHLauri T. A. Holmström
Lauri T. A. Holmström
TKTuomas V. Kenttä
Tuomas V. Kenttä
MHM. Anette E. Haukilahti
M. Anette E. Haukilahti
Juhani JunttilaJuhani Junttila
Juhani Junttila
Sudden cardiac death (SCD) is a worldwide major public health burden, accounting for more than 50% of all cardiac deaths and 20% of all deaths in the United States.1,2 Coronary artery disease (CAD) is the most common underlying cause of SCD.3 Often, SCD is the first recognized clinical manifestation of underlying heart disease, and the ability to recognize this specific risk before the event is severely limited.4

1 December 2014 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
AEAntti Eranti
Antti Eranti
AAAapo L. Aro
Aapo L. Aro
TKTuomas Kerola
Tuomas Kerola
OAOlli Anttonen
Olli Anttonen
HRHarri A. Rissanen
Harri A. Rissanen
HHHeikki V. Huikuri
Heikki V. Huikuri
Background—: Prevalence and prognostic significance of abnormal P terminal force (PTF) in the general population are not known. The aim of this study was to assess the prevalence of abnormal PTF and to compare clinical outcomes of middle-aged subjects with and without the PTF. Methods and Results—: The presence of PTF was assessed in a cohort of 10 647 middle-aged subjects (mean age [SD], 44 [8] years; 47.2% female). The subjects were followed 35 to 41 years, and data on mortality and hospitalizations were obtained from national registers. Primary outcomes were all-cause mortality, cardiac mortality, and arrhythmic death. Secondary outcomes were hospitalization because of congestive heart failure, coronary heart disease, new onset atrial fibrillation, and stroke. The Cox proportional hazards model was used to assess the risk for death (all-cause), and the Fine and Gray competing risks model was used for other outcomes. The prevalence of PTF 0.04 to 0.049, 0.05 to 0.059, and ≥0.06 mm·s were 4.8%, 1.5%, and 1.2%, respectively. Subjects presenting PTF ≥0.04 mm·s were at increased risk for death, cardiac death, and congestive heart failure, and subjects presenting PTF ≥0.06 mm·s were at increased risk for atrial fibrillation. However, after adjustment for potential confounding factors, an increased risk was observed only for death (hazard ratio, 1.76; 95% confidence interval, 1.45–2.12; P <0.001) and atrial fibrillation (hazard ratio, 1.91; 95% confidence interval, 1.34–2.73; P <0.001) in subjects presenting PTF ≥0.06 mm·s. Conclusions—: PTF ≥0.04 mm·s is a relatively common finding in a 12-lead ECG of middle-aged subjects. PTF ≥0.06 mm·s is associated with increased risk for atrial fibrillation and death in the general population.